Prokinecitine in Acute Myocardial Infarction (Prok-Idm)

University Hospital, Strasbourg, France

Status: Terminated

Conditions: ST Elevatation Myocardial Infarction (STEMI)

Study type: Observational

Funder types: Other

Identifiers

NCT02021487

5515

Details and patient eligibility

About

The study aims to investigate the presence of a substance in the blood called prokinecitine, which is released by the heart when a heart attack occurs. Several venous blood samples at the arm are withdrawn at admission, H6, H12, H24, H48 and H72 in order to measure the concentration of this substance in the blood. The usefulness of this new blood marker is going to be determsined to seek if it would be of help to better diagnose or estimate the gravity of heart infarction after a heart attack.

Enrollment: 172 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with acute St elevation myocardial infarction of less than 6 hours
• Age>18 y/o

Exclusion criteria

• Previous myocardial infarction
• LBB, RBB
• Renal Insuffiency MDRD<30 mL/min
• Patient with Pace-Maker or ICD.